Logo

Molecular profiling can safely reduce radiation for women with endometrial cancer: Clinical trial results

Molecular profiling can safely reduce radiation for women with endometrial cancer: Clinical trial results

Endometrial cancer is the most common gynecological cancer in highly-developed countries, most often affecting women after menopause. The majority of women are diagnosed at an early stage, when treatment outcomes are generally favorable.

👉 Full Story